Targeting the Delivery of Glycan-Based Paclitaxel Prodrugs to Cancer Cells via Glucose Transporters
Abstract
This report describes the synthesis of four novel paclitaxel based prodrugs with glycan conjugation (1-4). Glycans were conjugated using an ester or ether bond as the linker between 2'-paclitaxel and the 2'-glucose or glucuronic acid moiety. These prodrugs showed good water solubility and selective cytotoxicity against cancer cell lines, but showed reduced toxicity toward normal cell lines and cancer cell lines with low expression levels of GLUTs. The ester conjugated prodrug 1 showed the most cytotoxicity among the prodrugs examined and could be transported into cells via GLUTs. Fluorescent and confocal microscopy demonstrated that targeted cells exhibited morphological changes in tubulin and chromosomal alterations that were similar to those observed with paclitaxel treatment. Therefore, these glycan-based prodrugs may be good drug candidates for cancer therapy, and the glycan conjugation approach is an alternative method to enhance the targeted delivery of other drugs to cancer cells that overexpress GLUTs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glucose conjugates of several cancer chemotherapeutics, including paclitaxel and doxorubicin, experienced a higher therapeutic efficacy in vivo.
“Glucose conjugates of several cancer chemotherapeutics, including paclitaxel and doxorubicin [159,160,161], experienced a higher therapeutic efficacy in vivo.”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [159]
Cites
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229 · see citing works
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
Flier, J. S., Mueckler, M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 778 · see citing works
Horwitz, S. B. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90048-b · Cited by 741 · see citing works
Enzyme-Catalyzed Activation of Anticancer Prodrugs
Rooseboom, M., Commandeur, J. N. M., & Vermeulen, N. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.3 · Cited by 498 · see citing works
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 491 · see citing works
Prestwich, G. D., Marecak, D. M., Marecek, J. F., Vercruysse, K. P., & Ziebell, M. R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00242-3 · Cited by 423 · see citing works
Taxol-induced polymerization of purified tubulin. Mechanism of action.
Kumar, N. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68639-4 · Cited by 404 · see citing works
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 385 · see citing works
Cancer biomarkers: knowing the present and predicting the future
Chatterjee, S. K., & Zetter, B. R. (2005) · Future Oncology · doi:10.1517/14796694.1.1.37 · Cited by 266 · see citing works
18F-FDG imaging: pitfalls and artifacts.
Abouzied, M., Crawford, E. S., & Nabi, H. A. (2005) · PubMed · Cited by 247 · see citing works
Elucidation of the mechanism enabling tumor selective prodrug monotherapy.
Bosslet, K., Straub, R. H., Blumrich, M., Czech, J., Gerken, M., Sperker, B., Kroemer, H. K., Gesson, J., Koch, M. C., & Monneret, C. (1998) · PubMed · Cited by 225 · see citing works
A folate receptor-targeted liposomal formulation for paclitaxel
Wu, J., Liu, Q., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.027 · Cited by 212 · see citing works
Gleadle, J., & Ratcliffe, P. J. (1997) · Blood · doi:10.1182/blood.v89.2.503 · Cited by 182 · see citing works
Paclitaxel Prodrugs: Toward Smarter Delivery of Anticancer Agents
Skwarczyński, M., Hayashi, Y., & Kiso, Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0602155 · Cited by 170 · see citing works
Beta-Glucuronidase-Mediated Drug Release
de Graaf, M., Boven, E., Scheeren, H. W., Haisma, H. J., & Pinedo, H. M. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394485 · Cited by 158 · see citing works
Ericsson, A., Hamark, B., Powell, T. L., & Jansson, T. (2004) · Human Reproduction · doi:10.1093/humrep/deh596 · Cited by 127 · see citing works
de Groot, F. M. H., van Berkom, L. W. A., & Scheeren, H. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0009078 · Cited by 104 · see citing works
Ceramide induces apoptosis in PC12 cells
Hartfield, P. J., Mayne, G. C., & Murray, A. W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01460-3 · Cited by 104 · see citing works
Ishida, H., Irie, K., Itoh, T., Furukawa, T., & Tokunaga, O. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970915)80:6 · Cited by 101 · see citing works
Nguyen, X. C., Lee, W., Chung, J.-H., Park, S. Y., Sung, S. W., Kim, Y. K., So, Y., Lee, D. S., Chung, J.-K., Lee, M. C., et al. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.12.008 · Cited by 96 · see citing works
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia
Funasaka, T., Yanagawa, T., Hogan, V. A., & Raz, A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3699com · Cited by 93 · see citing works
Expression and function of β-glucuronidase in pancreatic cancer: potential role in drug targeting
Sperker, B., Werner, U., Mürdter, T. E., Tekkaya, C., Fritz, P., Wacke, R., Adam, U., Gerken, M., Drewelow, B., & Kroemer, H. K. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000260 · Cited by 90 · see citing works
Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis
Huang, C., Wu, Y., & Chen, S.-T. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00131-9 · Cited by 88 · see citing works
Self-citationHypoxia in head and neck cancer
Isa, A., Ward, T. H., West, C., Slevin, N. J., & Homer, J. J. (2006) · British Journal of Radiology · doi:10.1259/bjr/17904358 · Cited by 83 · see citing works
Active Site Residues of Human β-Glucuronidase
Islam, M. R., Tomatsu, S., Shah, G. N., Grubb, J. H., Jain, S., & Sly, W. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23451 · Cited by 78 · see citing works
Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue
Damen, E. W. P., Nevalainen, T., van den Bergh, T. J. M., de Groot, F. M. H., & Scheeren, H. W. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00235-8 · Cited by 64 · see citing works
Oncologic imaging in gynecologic malignancies.
Pandit-Taskar, N. D. (2005) · PubMed · Cited by 57 · see citing works
Liu, D.-Z., Sinchaikul, S., Reddy, P. V. G., Chang, M.-Y., & Chen, S.-T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.008 · Cited by 53 · see citing works
Self-citationThe transport and binding of taxol
Parekh, H. K., & Simpkins, H. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)89716-9 · Cited by 51 · see citing works
Kant, J., Huang, X. S., Wong, H., Fairchild, C. A., Vyas, D. M., & Farina, V. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80980-x · Cited by 48 · see citing works
Abraham, S., Guo, F., Li, L., Rader, C. M., Liu, C., Barbas, C. F., Lerner, R. A., & Sinha, S. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700223104 · Cited by 40 · see citing works
Phloridzin and phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in vitro and in vivo.
Nelson, J. A., & Falk, R. E. (1994) · PubMed · Cited by 39 · see citing works
Paik, J.-Y., Lee, K.-H., Ko, B.-H., Choe, Y. S., Choi, Y. W., & Kim, B. (2005) · PubMed · Cited by 39 · see citing works
Glucose Uptake via Glucose Transporter 3 by Human Platelets Is Regulated by Protein Kinase B
Ferreira, I. A., Mocking, A. I. M., Urbanus, R. T., Varlack, S., Wnuk, M., & Akkerman, J. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507221200 · Cited by 34 · see citing works
Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Ferlini, C., Ojima, I., Distefano, M., Gallo, D., Riva, A., Morazzoni, P., Bombardelli, E., Mancuso, S., & Scambia, G. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033353489 · Cited by 29 · see citing works
Effects of taxol treatment on the microtubular system and mitochondria of Tetrahymena
Kovacs, P. L., CSABA, G., Pállinger, É., & Czaker, R. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.01.004 · Cited by 27 · see citing works
Mittal, S., Song, X., Vig, B. S., & Amidon, G. L. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9249-9 · Cited by 26 · see citing works
Protein kinase C-ζ regulation of GLUT4 translocation through actin remodeling in CHO cells
Liu, X., Yang, C. H., Gupta, N., Zuo, J., Chang, Y., & Fang, F. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0232-z · Cited by 24 · see citing works
Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer
Nabholtz, J., Vannetzel, J.-M., Llory, J., & Bouffette, P. (2003) · Clinical Breast Cancer · doi:10.1016/s1526-8209(11)70624-3 · Cited by 22 · see citing works
Shen, S. I., Kotamraj, P. R., Bhattacharya, S., Li, X., & Jasti, B. (2007) · Journal of drug targeting · doi:10.1080/10611860601035212 · Cited by 19 · see citing works
Sakyo, T., Naraba, H., Teraoka, H., & Kitagawa, T. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05814.x · Cited by 14 · see citing works
Glucose uptake in the human gastric cancer cell line, MKN28, is increased by insulin stimulation
Noguchi, Y., Sato, S., Marat, D., Doi, C., Yoshikawa, T., Saito, A., Ito, T., Tsuburaya, A., & Yanuma, S. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00054-3 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Glucose Conjugation for the Specific Targeting and Treatment of Cancer
Calvaresi, E. C., & Hergenrother, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22205e · Cited by 398 · see citing works
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Walther, R., Rautio, J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.013 · Cited by 293 · see citing works
Pearce, A. K., & O’Reilly, R. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00456 · Cited by 280 · see citing works
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · see citing works
Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules
Gantt, R. W., Peltier, P., & Thorson, J. S. (2011) · Natural Product Reports · doi:10.1039/c1np00045d · Cited by 245 · see citing works
Glucose Transporters as a Target for Anticancer Therapy
Pliszka, M., & Szablewski, L. (2021) · Cancers · doi:10.3390/cancers13164184 · Cited by 208 · see citing works
Paclitaxel drug delivery systems
Zhang, Z., Mei, L., & Feng, S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.752354 · Cited by 182 · see citing works
Suriano, F., Pratt, R. C., Tan, J. P. K., Wiradharma, N., Nelson, A., Yang, Y. Y., Dúbois, P., & Hedrick, J. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.022 · Cited by 177 · see citing works
Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility
Müller, C. E. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900114 · Cited by 146 · see citing works
Small Molecules for Active Targeting in Cancer
Kue, C. S., Kamkaew, A., Burgess, K., Kiew, L. V., Chung, L. Y., & Lee, H. B. (2016) · Medicinal Research Reviews · doi:10.1002/med.21387 · Cited by 143 · see citing works
Designing polymers with sugar-based advantages for bioactive delivery applications
Zhang, Y., Chan, J. W., Moretti, A., & Uhrich, K. E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.053 · Cited by 139 · see citing works
Barbosa, A. M., & Martel, F. (2020) · Cancers · doi:10.3390/cancers12010154 · Cited by 137 · see citing works
Application of targeted drug delivery system in Chinese medicine
Li, D.-C., Zhong, X., Zeng, Z., Jiang, J., Li, L., Zhao, M., Yang, X., Chen, J., Ben-shan, Z., Zhao, Q., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.008 · Cited by 122 · see citing works
Developments in Carbohydrate-Based Cancer Therapeutics
Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 120 · see citing works
Prodrug Strategies for Paclitaxel
Meng, Z., Lv, Q., Lu, J. G., Yao, H., Lv, X., Jiang, F., Lü, A., & Zhang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050796 · Cited by 93 · see citing works
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He, Q., Minn, I., Wang, Q., Xu, P. H., Head, S. A., Datan, E., Yu, B., Pomper, M. G., & Liu, J. O. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606121 · Cited by 82 · see citing works
Beck, D. E., Agama, K., Marchand, C., Chergui, A., Pommier, Y. G., & Cushman, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401814y · Cited by 74 · see citing works
Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment
Fu, J., Yang, J., Seeberger, P. H., & Yin, J. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108195 · Cited by 73 · see citing works
Anticancer agents interacting with membrane glucose transporters
Granchi, C., Fortunato, S., & Minutolo, F. (2016) · MedChemComm · doi:10.1039/c6md00287k · Cited by 71 · see citing works
Caron, J., Maksimenko, A., Wack, S., Lepeltier, É., Bourgaux, C., Morvan, E., Leblanc, K., Couvreur, P., & Desmaële, D. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200099 · Cited by 67 · see citing works
Kramer, W. (2011) · Biological Chemistry · doi:10.1515/bc.2011.017 · Cited by 63 · see citing works
Wang, H., He, J., Cao, D., Zhang, M., Li, F., Tam, K. C., & Ni, P. (2015) · Polymer Chemistry · doi:10.1039/c5py00569h · Cited by 58 · see citing works
Dual Targeting of the Warburg Effect with a Glucose‐Conjugated Lactate Dehydrogenase Inhibitor
Calvaresi, E. C., Granchi, C., Tuccinardi, T., Bussolo, V. D., Huigens, R. W., Lee, H. Y., Palchaudhuri, R., Macchia, M., Martinelli, A., Minutolo, F., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201300562 · Cited by 56 · see citing works
New Cyclodextrin‐Bearing 8‐Hydroxyquinoline Ligands as Multifunctional Molecules
Oliveri, V., Puglisi, A., Viale, M., Aiello, C., Sgarlata, C., Vecchio, G., Clarke, J., Milton, J., & Spencer, J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300237 · Cited by 53 · see citing works
A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy
Shan, L., Cui, S., Du, C., Wan, S., Qian, Z., Achilefu, S., & Gu, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.025 · Cited by 49 · see citing works
Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators
Akam, E. A., & Tomat, E. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00332 · Cited by 48 · see citing works
Zhang, G., Zhang, M., He, J., & Ni, P. (2013) · Polymer Chemistry · doi:10.1039/c3py00419h · Cited by 47 · see citing works
Lai, C., Chang, T., Chuang, Y., Tzou, D. M., & Lin, C. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400219t · Cited by 45 · see citing works
Domiński, A., Krawczyk, M., Konieczny, T., Kasprów, M., Foryś, A., Pastuch-Gawołek, G., & Kurcok, P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.07.019 · Cited by 44 · see citing works
Shityakov, S., Roewer, N., Broscheit, J., & Förster, C. Y. (2017) · Computational Toxicology · doi:10.1016/j.comtox.2017.02.003 · Cited by 42 · see citing works
Polymer prodrug approaches applied to paclitaxel
Sohn, J. S., Jin, J. I., Heß, M., & Jo, B. (2010) · Polymer Chemistry · doi:10.1039/b9py00351g · Cited by 41 · see citing works
Biological evaluation of Paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery
Yamada, R., Kostova, M. B., Anchoori, R. K., Xu, S., Neamati, N., & Khan, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10656 · Cited by 40 · see citing works
Synthesis of new triazole linked carbohybrids with ROS-mediated toxicity in breast cancer
Kumari, P., Dubey, S., Venkatachalapathy, S., Narayana, C., Gupta, A. K., & Sagar, R. (2019) · New Journal of Chemistry · doi:10.1039/c9nj03288f · Cited by 39 · see citing works
Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis and in Vitro Evaluation
Ndungu, J. M., Lu, Y., Zhu, S., Yang, C., Wang, X., Chen, G. Z., Shin, D. M., Snyder, J. P., Shoji, M., & Sun, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901763f · Cited by 37 · see citing works
A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy
Pastuch-Gawołek, G., Szreder, J., Domińska, M., Pielok, M., Cichy, P., & Grymel, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030913 · Cited by 36 · see citing works
Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel
Xie, C., Chang, J., Hao, X., Yu, J., Liu, H., & Sun, X. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.008 · Cited by 35 · see citing works
Nanoformulation of paclitaxel to enhance cancer therapy
Gu, Q., Xing, J. Z., Huang, M., Zhang, X., & Chen, J. (2012) · Journal of Biomaterials Applications · doi:10.1177/0885328212446822 · Cited by 34 · see citing works
Zuo, H., Zhang, C., Zhang, Y., & Niu, D. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309887 · Cited by 33 · see citing works
Glycoconjugation: An approach to cancer therapeutics
Molejon, M. I., Weiz, G., Breccia, J. D., & Molejon, M. I. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i3.110 · Cited by 32 · see citing works
Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors
Upadhyaya, K., Hamidullah, H., Singh, K., Arun, A., Shukla, M. K., Srivastava, N., Ashraf, R., Sharma, A., Mahar, R., Shukla, S. K., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02113h · Cited by 31 · see citing works
Glycopolymer and Poly(β-amino ester)-Based Amphiphilic Block Copolymer as a Drug Carrier
Sahkulubey, E. L., Kahveci, M. U., Çelebi, A., Avşar, T., & Derman, S. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c01076 · Cited by 30 · see citing works
Wu, X., Tian, Y., Yu, M., Han, J., & Han, S. (2014) · Biomaterials Science · doi:10.1039/c4bm00007b · Cited by 29 · see citing works
Kumar, M., Sharma, G., Kumar, R., Singh, B., Katare, O. P., & Raza, K. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b01031 · Cited by 28 · see citing works
Delavari, B., Mamashli, F., Bigdeli, B., Poursoleiman, A., Karami, L., Zolmajd-Haghighi, Z., Ghasemi, A., Samaei‐Daryan, S., Hosseini, M., Haertlé, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35559-1 · Cited by 28 · see citing works
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Weng, H., Li, J., Zhu, H., Wong, K. F. C., Zhu, Z., & Xu, J. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0212 · Cited by 27 · see citing works
Zi, C., Yang, D., Dong, F.-W., Li, G., Li, Y., Ding, Z., Zhou, J., Jiang, Z., & Hu, J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.021 · Cited by 26 · see citing works
Bahuguna, S., Kumar, M., Sharma, G., Kumar, R., Singh, B., & Raza, K. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0920-0 · Cited by 26 · see citing works
Mao, Y., Zhang, Y., Luo, Z., Zhan, R., Xu, H. F., Chen, W., & Huang, H. (2018) · Molecules · doi:10.3390/molecules23123211 · Cited by 25 · see citing works
Zi, C., Xu, F.-Q., Li, G., Li, Y., Ding, Z., Zhou, J., Jiang, Z., & Hu, J. (2013) · Molecules · doi:10.3390/molecules181113992 · Cited by 25 · see citing works
Gu, X., Chen, L., Wang, X., Liu, X., You, Q., Xi, W., Gao, L., Chen, G., Chen, Y.-L., Xiong, B., et al. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo402551x · Cited by 25 · see citing works
Advances in oral delivery of anti-cancer prodrugs
Jain, A., & Jain, S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1200554 · Cited by 25 · see citing works
Guo, X., Song, J., Liu, M., Ou, X., & Guo, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2356831 · Cited by 24 · see citing works
Dhakne, P., Pillai, M. S., Mishra, S., Chatterjee, B., Tekade, R. K., & Sengupta, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188906 · Cited by 23 · see citing works
Targeting Toxins toward Tumors
Franzyk, H., & Christensen, S. B. (2021) · Molecules · doi:10.3390/molecules26051292 · Cited by 22 · see citing works
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He, Q., Minn, I., Wang, Q., Xu, P. H., Head, S. A., Datan, E., Yu, B., Pomper, M. G., & Liu, J. O. (2016) · Angewandte Chemie · doi:10.1002/ange.201606121 · Cited by 20 · see citing works
“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy
Ding, N., Xu, S., Zheng, S., Ye, Q., Xu, L. L., Ling, S., Xie, S., Chen, W., Zhang, Z., Xue, M., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02787a · Cited by 19 · see citing works
Khuphe, M., Mahon, C. S., & Thornton, P. D. (2016) · Biomaterials Science · doi:10.1039/c6bm00535g · Cited by 19 · see citing works
Synthesis and antiproliferative activity of new chlorin e6 glycoconjugates
Kuzmina, N. S., Otvagin, V. F., Krylova, L. V., Nyuchev, A. V., Romanenko, Y. V., Койфман, О. И., Balalaeva, I. V., & Fedorov, A. Y. (2020) · Mendeleev Communications · doi:10.1016/j.mencom.2020.03.009 · Cited by 18 · see citing works
Zi, C., Yang, L., Gao, W., Li, Y., Zhou, J., Ding, Z., Hu, J., & Jiang, Z. (2017) · ChemistrySelect · doi:10.1002/slct.201700347 · Cited by 17 · see citing works
Sung, Y., Kerimoğlu, B., Ooi, A., & Tomat, E. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00250 · Cited by 17 · see citing works
Domińska, M., Pastuch-Gawołek, G., Skonieczna, M., Szeja, W., Domiński, A., & Kurcok, P. (2022) · Molecules · doi:10.3390/molecules27206918 · Cited by 16 · see citing works
Tiwari, G., Mishra, V. K., Kumari, P., Khanna, A., Sharma, S., & Sagar, R. (2024) · RSC Advances · doi:10.1039/d3ra06993a · Cited by 15 · see citing works
Bennai, N., Chabrier, A., Fatthalla, M. I., Tran, C., Yen‐Pon, E., Belkadi, M., Alami, M., Grimaud, L., & Messaoudi, S. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00766 · Cited by 15 · see citing works
Daragics, K., Szabó, P. T., & Fügedi, P. (2011) · Carbohydrate Research · doi:10.1016/j.carres.2011.04.046 · Cited by 15 · see citing works
Wang, Y., Shen, X., Su, F., Xie, Y.-R., Wang, L., Zhang, N., Wu, Y.-L., Niu, Y., Zhang, D., Zi, C., et al. (2021) · Molecules · doi:10.3390/molecules26144361 · Cited by 13 · see citing works
Random versus Block Glycopolymers Bearing Betulin and Porphyrin for Enhanced Photodynamic Therapy
Ma, Z., An, R., Chen, M., Wang, X., & Zhu, M. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00922 · Cited by 13 · see citing works
栗增, 柳红, 王江, & 周宇 (2014) · PubMed · Cited by 13 · see citing works
Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells
Buchanan, M. K., Needham, C. N., Neill, N. E., White, M. C., Kelly, C. B., Mastro-Kishton, K., Chauvignè-Hines, L. M., Goodwin, T. J., McIver, A. L., Bartolotti, L. J., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01075 · Cited by 13 · see citing works
Tiwari, G., Khanna, A., Tyagi, R., Mishra, V. K., Narayana, C., & Sagar, R. (2024) · Scientific Reports · doi:10.1038/s41598-023-50202-4 · Cited by 12 · see citing works
Lin, J., Ma, Z., Zuo, W., & Zhu, M. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01378 · Cited by 12 · see citing works
Meng, X., Lian, X., Li, X., Ya, Q., Li, T., Zhang, Y., Yang, Y., & Zhang, Y. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108034 · Cited by 12 · see citing works
Enzymatic activation of a matrix metalloproteinase inhibitor
Jourden, J. L. M., & Cohen, S. M. (2010) · Chemical Communications · doi:10.1039/b923302d · Cited by 12 · see citing works
Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells
Mohammadi, A., Kazemipour, N., Ghorbankhani, G. A., Morovati, S., & Sadeghian, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68765-1 · Cited by 11 · see citing works
Shafi, S., Khan, M. A., Ahmad, J., Rabbani, S. A., Singh, S., & Najmi, A. K. (2024) · Current Drug Targets · doi:10.2174/0113894501335877240926101134 · Cited by 10 · see citing works
Mojtahedi, M. M., Mehraban, M., Darvishi, K., & Abaee, M. S. (2017) · Heterocyclic Communications · doi:10.1515/hc-2017-0014 · Cited by 10 · see citing works
Yang, C., Xia, A., Du, C., Hu, M., Gong, Y., Tian, R., Jiang, X., & Xie, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014854 · Cited by 10 · see citing works
El‐Dakdouki, M. H., & Erhardt, P. (2012) · Pure and Applied Chemistry · doi:10.1351/pac-con-12-02-13 · Cited by 10 · see citing works
Cybulski, M., Sidoryk, K., Zaremba-Czogalla, M., Trzaskowski, B., Kubiszewski, M., Tobiasz, J., Jaromin, A., & Michalak, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052573 · Cited by 9 · see citing works
Galacturonic acid-capsaicin prodrug for prolonged nociceptive-selective nerve blockade
Li, Q., Li, X., Zhang, Y., Yang, Q., Hathcock, S. F., Cai, Y., Busa, P., Pang, S., Tan, L., Kim, B. J., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.046 · Cited by 9 · see citing works
Konakahara, T., Sato, N., Kawai, Y., Akaba, Y., Honma, S., & Sakai, N. (2016) · Heterocycles · doi:10.3987/com-16-13404 · Cited by 9 · see citing works
Anti-cancer agents and reactive oxygen species modulators that target cancer cell metabolism
Ndombera, F. T. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2016-1219 · Cited by 9 · see citing works
Progress in Cancer Nanotechnology
Majoros, I., Ward, B. B., Lee, K.-H., Choi, S. K., Huang, B., Myc, A., & Baker, J. R. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00008-3 · Cited by 7 · see citing works
Lopopolo, G., de Candia, M., Panza, L., Romano, M. R., Lograno, M. D., Campagna, F., & Altomare, C. (2012) · ChemMedChem · doi:10.1002/cmdc.201200224 · Cited by 7 · see citing works
In vivo biological evaluation of 131I radiolabeled-paclitaxel glucuronide (131I-PAC-G)
Aslan, O., Müftüler, F. Z. B., Kılçar, A. Y., İçhedef, Ç., & Ünak, P. (2012) · Radiochimica Acta · doi:10.1524/ract.2012.1922 · Cited by 7 · see citing works
Cell line studies and analytical measurements of three paclitaxel complex variations
Manning, T. J., Plummer, S., Woods, R., Wylie, G., Phillips, D. R., & Krajewski, L. C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.070 · Cited by 7 · see citing works
Zhou, G., Li, X., Teng, M. F., Chu, G.-H., & Lin, X. (2011) · Journal of Applied Polymer Science · doi:10.1002/app.35201 · Cited by 6 · see citing works
Bioavailability of 99mTc-paclitaxel-glucuronide (99mTc-PAC-G)
Müftüler, F. Z. B., Demir, I., Ünak, P., İçhedef, Ç., & Kılçar, A. Y. (2011) · Radiochimica Acta · doi:10.1524/ract.2011.1827 · Cited by 6 · see citing works
Hilali, M. E., Reux, B., Débiton, E., Leal, F., Galmier, M., Vivier, M., Chezal, J., Miot-Noirault, E., Coudert, P., & Weber, V. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.043 · Cited by 6 · see citing works
Wang, Z., Liu, R., Zhang, X., Chang, X., Gao, M., Zhang, S., Guan, Q., Sun, J. F., Zuo, D., & Zhang, W. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116671 · Cited by 5 · see citing works
Borane–Trimethylamine Complex: A Versatile Reagent in Organic Synthesis
Perdicchia, D. (2024) · Molecules · doi:10.3390/molecules29092017 · Cited by 4 · see citing works
Synthesis of a glucose conjugate of pristimerin and evaluation of its anticancer activity
Yang, F., Zhang, J., Li, J., Ye, W., Li, A., & He, W. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.04.036 · Cited by 4 · see citing works
Possibilities of Cancer Chemotherapy Based on Transporter-Conscious Drug Design
Tashima, T. (2015) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000233 · Cited by 4 · see citing works
A phenanthroindolizidine glycoside with HIF-1 inhibitory activity from Tylophora atrofolliculata
Chen, C., Zhu, G., Xie, T.-G., Jiang, P.-C., Wang, J., & Jiang, Z. (2019) · Phytochemistry Letters · doi:10.1016/j.phytol.2019.03.003 · Cited by 4 · see citing works
Wang, Q., Wang, D., Li, D., Lu, J., & Wei, Q. (2015) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/1/4/045009 · Cited by 4 · see citing works
Motz, R. N., Anderson, J. K., & Nolan, E. M. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00581 · Cited by 3 · see citing works
Zuo, H., Zhang, C., Zhang, Y., & Niu, D. (2023) · Angewandte Chemie · doi:10.1002/ange.202309887 · Cited by 3 · see citing works
Li, X., Zhang, H., Dong, S., Gao, X., Sun, H., Zhou, Z., Hu, K., Guo, S., Zhang, Q., Guo, Z., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117843 · Cited by 3 · see citing works
Li, H., Li, B., Sun, X., Ma, H., Zhu, M., Dai, Y., Ma, T., Li, Y., Hong, Y., & Wu, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127282 · Cited by 3 · see citing works
Developing Ligands to Target Transition Metals in Cancer
Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3 · see citing works
Synthesis and anticancer potential of glycosides
Ali, S., Rukh, G., Ogaly, H. A., Ajaj, R., Rauf, A., & Shah, S. A. A. (2025) · RSC Advances · doi:10.1039/d5ra07626a · Cited by 2 · see citing works
- Authors
- Lin, Y.-S., Tungpradit, R., Sinchaikul, S., An, F.-M., Liu, D.-Z., Phutrakul, S., & Chen, S.-T.
- Affiliations
- National Taiwan University (TW)
- Corresponding author
- Chen, Shui-Tein
- ORCID
- Liu, Der-Zen
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-11-16
- Volume
- 51
- Issue
- 23
- Pages
- 7428-7441
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2095581830
- Cited by
- 120
- References
- 43
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 13 · 2023: 6 · 2022: 8 · 2021: 4 · 2020: 8 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 11 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 6
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and biological activity
- Keywords
- paclitaxel prodrug, glucose transporters, glucuronic acid, cytotoxicity, tubulin, anticancer drug delivery
- MeSH terms
- Animals, Cell Line, Cricetulus, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Cricetinae, Humans, Polysaccharides, Prodrugs, Stereoisomerism, Drug Design, Molecular Structure, CHO Cells, Drug Delivery Systems, Paclitaxel, Cell Proliferation, Glucose Transport Proteins, Facilitative
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review